Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

The FDA approved Yeztugo (lenacapavir), a twice-yearly injection that prevents HIV with up to 99.9% effectiveness, showing ...

The US FDA has approved lenacapvir, sold under the brand name Yeztugo, as the first preventive treatment against HIV. It is a ...

Groundbreaking twice-a-year HIV drug that could stop transmission approved - It's unclear how many people in the US and ...

Cancer patients say they’ve grown sicker since Argentina’s radical libertarian President Javier Milei took his chainsaw to ...

A new study found that implementing a specialty pharmacy program at St. Jude Children’s Research Hospital helped more young ...

For many, the fear of social exclusion or cultural taboos discouraged them from both testing for HIV and adhering to ART treatment: There are people who say that there is a traditional treatment ...

In 2024, Zambia received $240 million from the U.S. to support HIV/AIDS work, including prevention, treatment and distribution ... to prepare nshima — a thick traditional porridge — for ...